Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOCETAXEL Cause Malignant neoplasm progression? 2,199 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,199 reports of Malignant neoplasm progression have been filed in association with DOCETAXEL (Docetaxel). This represents 3.4% of all adverse event reports for DOCETAXEL.

2,199
Reports of Malignant neoplasm progression with DOCETAXEL
3.4%
of all DOCETAXEL reports
609
Deaths
344
Hospitalizations

How Dangerous Is Malignant neoplasm progression From DOCETAXEL?

Of the 2,199 reports, 609 (27.7%) resulted in death, 344 (15.6%) required hospitalization, and 57 (2.6%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOCETAXEL. However, 2,199 reports have been filed with the FAERS database.

What Other Side Effects Does DOCETAXEL Cause?

Alopecia (29,347) Emotional distress (8,373) Anxiety (7,379) Psychological trauma (6,981) Madarosis (6,883) Hair texture abnormal (6,204) Hair colour changes (6,078) Hair disorder (5,652) Pain (5,414) Diarrhoea (4,115)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which DOCETAXEL Alternatives Have Lower Malignant neoplasm progression Risk?

DOCETAXEL vs DOCETAXEL ANHYDROUS DOCETAXEL vs DOCETAXEL\DOCETAXEL ANHYDROUS DOCETAXEL vs DOCONEXENT DOCETAXEL vs DOCONEXENT\ICOSAPENT DOCETAXEL vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE

Related Pages

DOCETAXEL Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression DOCETAXEL Demographics